Iovance Biotherapeutics (IOVA) Reports Q3 Loss, Tops Revenue Estimates

Iovance Biotherapeutics (IOVA) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of$ 0.31. This compares to loss of $0.46 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 9.68%. A quarter ago, it was expected that this biotechnology company would post a loss of$ 0.37 per share when it actually produced a loss of $0.34, delivering a surprise of 8.11%.Over the last four quarters, the ...